MedTrace Logo

Treatment Goals in Psoriatic Arthritis

NCT03620188 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2023-09-21

No results posted yet for this study

Summary

The PaGoPsA study objective is to ascertain if guideline-based psoriatic arthritis clinical care achieves individual patient goals as articulated by patients, and to identify predictors of achieving individual patient goals from psoriatic arthritis treatment.

Conditions

Interventions

OTHER

Standard of care

Standard of care in PsA is outline in treatment guidelines as adjustment of therapy every 3 months until goals of treatment are being met. Goals of treatment are defined as remission or low disease activity.

Sponsors & Collaborators

Principal Investigators

  • Ana-Maria Orbai, MD, MHS · Johns Hopkins University

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-20
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03620188 on ClinicalTrials.gov